Methadone + Dexmedetomidine + Ketamine for Pain Control in Spinal Surgery

This trial tests whether a combination of three medicines—methadone, dexmedetomidine, and ketamine—can better manage pain during and after complex spine surgeries. The goal is to determine if this combination reduces the need for opioid painkillers post-surgery. The trial includes two groups: one receives the new combination, and the other receives routine opioid-based anesthesia. It seeks participants undergoing spine surgeries on three or more levels who can speak English and consent to participate. As a Phase 4 trial, this research involves treatments already FDA-approved and proven effective, aiming to understand how they benefit more patients.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Research has shown that combining methadone, dexmedetomidine, and ketamine is generally safe for people. Studies have found that this mix can reduce the need for opioid painkillers after surgery. As a result, patients might experience less pain post-operation and use fewer opioids, which is beneficial given the risks associated with opioids.

While each drug in this combination has been used safely before, some considerations remain. For instance, ketamine might increase the chance of serious side effects in certain patients. This is important to consider when deciding to join a trial involving this combination.

Unlike the standard of care for pain control in spinal surgery, which typically involves opioid medications, the methadone-dexmedetomidine-ketamine combination being studied offers a unique approach. This treatment is administered intravenously during anesthesia and combines three active ingredients that may work synergistically to enhance pain relief while potentially reducing opioid consumption. Researchers are excited about this combination because methadone provides long-lasting pain relief, dexmedetomidine has sedative and analgesic properties, and ketamine offers pain relief with a unique mechanism that may prevent pain sensitization. This innovative approach could lead to more effective pain management with fewer side effects compared to traditional opioid-based treatments.

Research has shown that using methadone, dexmedetomidine, and ketamine together can help manage pain after surgery. In this trial, the intervention group will receive the methadone-dexmedetomidine-ketamine combination intravenously during anesthesia for complex spine surgery. These medications work well together to improve pain relief and reduce the need for additional opioids. Methadone and ketamine affect different pain pathways, enhancing their effectiveness. Studies also suggest that adding ketamine during spine surgeries can lower opioid use in the first 24 hours. This approach aims to make recovery more comfortable by better managing pain and reducing the need for stronger pain medications.¹²⁶⁷⁸